November 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreDecember 26, 2025
The medical device CMO and CDMO market size is is set to grow significantly, driven by evolving consumer prefe...
Read MoreDecember 26, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreDecember 26, 2025
According to market projections, the rotavirus vaccines market was valued at USD 5.25 billion in 2025 and is projected to grow from USD 5.78 billion in 2026 to USD 13.79 billion by 2035, registering a CAGR of 10.14% during the forecast period. The report covers detailed segment-wise data by vaccine type, route of administration, immunization progra...
December 26, 2025
Developing disease modeling and diverse therapies are fueling the global market expansion. North America led the market due to the presence of a robust and huge R&D base....
December 26, 2025
Market insights predict, the carrier screening industry is expected to grow from USD 3.09 billion in 2025 to USD 18.58 billion by 2035, driven by a CAGR of 19.65%. An immense growth in prenatal screening programs and early detection is mainly influencing the global market expansion. Whereas, the presence of robust healthcare policies and syst...
December 26, 2025
Based on market forecasts, the DNA methylation sector will expand from USD 2.05 billion in 2025 to USD 7.36 billion by 2035, experiencing a CAGR of 13.64%. The emerging trend of genomic imprinting and gene expression regulation drives the importance of DNA methylation. North America dominated the market in 2024 owing to the robust research and deve...
December 24, 2025
Market insights predict the recombinant albumin market was valued at USD 152.9 million in 2025 and is projected to grow from USD 162.2 million in 2026 to USD 275.89 million by 2035, registering a CAGR of 6.08% during the forecast period. The report provides detailed insights into market size, growth trends, dosage form segments, application segment...
December 24, 2025
Based on market forecasts, the residual DNA testing sector will expand from USD 310 million in 2024 to USD 552.93 million by 2034, experiencing a CAGR of 5.96%. The residual DNA testing market is rising due to strict regulations to ensure patient safety. North America dominates the market due to the presence of strong regulatory organizations....
December 24, 2025
Market insights predict the global in situ hybridization industry will increase from USD 1.55 billion in 2024 to USD 3.14 billion by 2034, achieving a CAGR of 7.33%. The in situ hybridization market is expanding due to its growing advancements as well as increasing demand for diagnostic approaches. North America led the market due to the presence o...
December 24, 2025
According to market projections, the CRISPR sector is expected to grow from USD 2.94 billion in 2024 to USD 8.58 billion by 2034, reflecting a CAGR of 11.24%. The market is growing due to rising demand for gene-editing therapies in genetic disorders and cancer treatment. Advancements in biotechnology and increased R&D investments are further ac...
December 24, 2025
According to forecasts, the global nanoparticle synthesis system market will grow from USD 0.7 billion in 2024 to USD 2.05 billion by 2034, with an expected CAGR of 11.34%. The nanoparticle synthesis system market is growing because nanoparticle synthesis systems have numerous major applications in healthcare, including drug delivery, tissue engine...
December 24, 2025
Market insights predict the global cell harvesting industry will increase from USD 6.71 billion in 2025 to USD 22.68 billion by 2035, achieving a CAGR of 12.95%. The cell harvesting market is expanding due to rising demand for cell and gene therapies as well as growing use of stem cell-based treatment approaches. North America led the market due to...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com